<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04112004</url>
  </required_header>
  <id_info>
    <org_study_id>ILBS - Liver Transplant-1</org_study_id>
    <nct_id>NCT04112004</nct_id>
  </id_info>
  <brief_title>Effect Of Delta Sodium on the Postoperative Outcomes in Liver Transplant Recipients</brief_title>
  <acronym>SOLT</acronym>
  <official_title>Effect of Perioperative Delta Sodium on Outcomes in Liver Transplant Recipients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institute of Liver and Biliary Sciences, India</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institute of Liver and Biliary Sciences, India</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      We analyzed the association of delta sodium levels with their effect on post liver transplant
      outcomes in consecutive patients undergoing liver transplantation. Records were analyzed for
      electrolytes and outcome measures, and data was analyzed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Preoperative hyponatremia was identified in patients. The mean change in sodium in
      hyponatremic patients was compared with inpatients with normal sodium levels. The impact of
      the delta sodium levels with short-term outcomes, such as duration of intubation, intensive
      care unit length of stay were analyzed with univariate and multivariate logistic regression
      analyses.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2011</start_date>
  <completion_date type="Actual">December 31, 2017</completion_date>
  <primary_completion_date type="Actual">December 31, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>change in serum sodium in liver transplant recipients</measure>
    <time_frame>1 day</time_frame>
    <description>difference between baseline and postoperative sodium in liver transplant recipients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>post transplant mortality</measure>
    <time_frame>1 month</time_frame>
    <description>post transplant mortality after liver transplantation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>post operative neurological complications</measure>
    <time_frame>1 month</time_frame>
    <description>Post operative neurological complications after liver transplantation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>duration of mechanical ventilation</measure>
    <time_frame>1 month</time_frame>
    <description>duration of mechanical ventilation after liver transplantation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of hospital stay</measure>
    <time_frame>1 month</time_frame>
    <description>Hospital stay after liver transplantation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of ICU stay</measure>
    <time_frame>1 month</time_frame>
    <description>Duration of ICU stay after liver transplantation</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">342</enrollment>
  <condition>Liver Transplant; Complications</condition>
  <condition>Perioperative/Postoperative Complications</condition>
  <condition>Electrolyte Disturbance</condition>
  <arm_group>
    <arm_group_label>Liver Transplant Recipients</arm_group_label>
    <description>All elective liver transplant recipients done between study period</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Collecting sodium reports and outcome measures</intervention_name>
    <arm_group_label>Liver Transplant Recipients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Liver transplant recipients more than 18 years in ILBS during study period
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All liver transplant recipients between Jan 2011 to Jan 2017

          -  Records available

        Exclusion Criteria:

          -  Acute fulminant liver failure

          -  All patients less than 18 years

          -  Re operated cases

          -  Pregnant patients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karthik T Ponnappan, DM</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute of Liver and Biliary Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institute of Liver and Biliary Sciences</name>
      <address>
        <city>New Delhi</city>
        <state>Delhi</state>
        <zip>110070</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>June 30, 2019</study_first_submitted>
  <study_first_submitted_qc>September 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 2, 2019</study_first_posted>
  <last_update_submitted>September 29, 2019</last_update_submitted>
  <last_update_submitted_qc>September 29, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 2, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Institute of Liver and Biliary Sciences, India</investigator_affiliation>
    <investigator_full_name>Karthik Ponnappan T</investigator_full_name>
    <investigator_title>Consultant</investigator_title>
  </responsible_party>
  <keyword>liver transplantation</keyword>
  <keyword>perioperative sodium</keyword>
  <keyword>sodium</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 1, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/04/NCT04112004/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

